Search results
Angel One, Motilal Oswal, IIFL shares fall up to 10% after SEBI asks MIIs to levy uniform fees |...
Livemint· 6 days agoCompanies in the broking industry experienced a sharp decline in their share values during today's...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 5 days agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Ajcon Global Services Ltd Stock Price: Ajcon Global Share Price Today | India Infoline
India Infoline· 3 days agoThe principal business of the company includes, Stock Broking, Corporate Advisory, Merchant Banking and Depository Participant Service.In 1994, the < ...
China's services activity growth hits 8-month low, shows Caixin PMI
Business Standard India· 5 days agoChina's services activity expanded at the slowest pace in eight months and confidence hit a...
Get your meetings right: Time is too valuable a resource
Livemint· 5 days agoAt the same time, whether it is in the sitcom The Office or Dilbert cartoons, or in our...
Mira launches online fertility clinic for people struggling to conceive
Medical Device Network· 4 days agoUS-based hormonal health company Mira has launched an online clinic that is set to provide...
Ahead of Market: 10 things that will decide stock action on Monday - The Economic Times
The Economic Times· 10 hours agoIndian markets saw another positive week with benchmark indices maintaining their winning streak. US...
Swastika Investmart Ltd Stock Price: Swastika Investm Share Price Today | India Infoline
India Infoline· 3 days agoThe Company is also involved in the field of Hire Purchase and Lease Finance.
Cartesian data add to progress, questions for CAR-T in autoimmune disease
BioPharma Dive· 5 days agoThe company claimed Phase 2 study results prove the therapy’s promise treating myasthenia gravis....
Tryptamine Therapeutics doses first subject in IV-infused psilocin trial
Clinical Trials Arena· 6 days agoA lead programme of Tryp, TRP-8803 is set to address several limitations of oral psilocybin therapy....